Forskning ved Københavns Universitet - Københavns Universitet

Forside

Allergisk rhinoconjunctivitis behandlet med intramuskulaert injiceret glukokortikoid

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Morten Dahl
  • L C Laursen
Effects and side effects of injectable depot steroid in the treatment of allergic rhinoconjunctivitis (hay fever) are described. A few controlled studies have shown injectable steroids to be superior to the effect of placebo and locally applied steroid. Over a period of 10 years from 1984-95 only 26 registered side effects were reported to the central Danish register for side effects of drugs (Laegemiddelstyrelsens Bivirkningsregister). Only eight concerned subcutaneous atrophy and in two cases the cutaneous changes persisted. Based on registration of number of treatments in the county of Funen 1996, it is estimated that the use of injectable depot steroids for treatment of hay fever accounts for about 535,000 DDD (defined daily doses corresponding to about 33,000 treatments per year). We conclude that the use of injectable corticosteroids in the treatment of hay fever is common and effective and side effects are very rare. However, injectable corticosteroids should only be used when conventional treatment is not sufficient to control symptoms.
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind160
Udgave nummer28
Sider (fra-til)4231-3
Antal sider3
ISSN0041-5782
StatusUdgivet - 6 jul. 1998

    Forskningsområder

  • Betamethasone, Delayed-Action Preparations, Glucocorticoids, Humans, Injections, Intramuscular, Methylprednisolone, Prednisolone, Rhinitis, Allergic, Seasonal

ID: 45524600